Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
Article
Strober, BE, Poulin, Y, Kerdel, FA et al. (2011). Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 64(4), 671-681. 10.1016/j.jaad.2010.03.009
Strober, BE, Poulin, Y, Kerdel, FA et al. (2011). Switching to adalimumab for psoriasis patients with a suboptimal response to etanercept, methotrexate, or phototherapy: Efficacy and safety results from an open-label study
. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 64(4), 671-681. 10.1016/j.jaad.2010.03.009